UAE and Indian hospital business Aster DM has tasked bankers to look at a demerger between the two geographies. Chairman Azad Moopen has said this makes more room for capex on the high-growth Indian business.
Australia's largest oncology provider Icon Group has been bought by EQT's infrastructure arm for AUS$2.4bn. Its CEO Mark Middleton tells HBI that the group now has its sights set on Europe.
The UK has just passed a new law that stands to shake up the procurement of healthcare services. The for-profit sector has hoped it could drive more patients to their businesses, especially against ballooning waiting lists and winter pressure, but experts tell HBI there's little chance it will increase outsourcing.
Adult social care, a major sector in the UK and Nordics in particular, has traditionally been dominated by the not-for-profit sector in Europe. In this week's infographic, we look at the for-profit, not-for-profit/public split across select countries in Europe.
African healthtech provider Helium Health has acquired Meddy, a Qatar and UAE-based doctor booking platform, with a view to expansion. HBI speaks to Adegoke Olubusi, Helium Health co-founder and CEO, to find out more.
Finland's largest for-profit healthcare operator by revenue Mehiläinen has made its first acquisition in Germany. The acquired hospital, Dalberg Klinik, is the ticket to further investments in the country's outpatient sector, HBI hears from Janne-Olli Järvenpää, Mehiläinen's CEO.
The Finnish competition regulator has approved Mehiläinen's acquisition of Vetrea's residential care business, showing that the big groups can still push for greater market share.
UK homecare group Cera Care is expanding its network with 15 digital healthcare hubs across the UK to deliver telehealth and medication services. The tech-savvy operator will further launch a digital flu tracker and treatment system. HBI talks with Igal Aciman, Chief Commercial Officer at Cera to find out more.
Thailand has re-opened for medical tourists without quarantine as the country seeks to revive its ailing medical tourism sector. We look at the impact that the 18-month ban has had on the country's big hospital groups Bumrungrad International Hospital and Bangkok Dusit Medical Services (BDMS).
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
